Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether sequential chemotherapy with capecitabine
plus oxaliplatin (Xelox) followed by docetaxel plus capecitabine (TX)in unresectable gastric
cancer.